TY - JOUR
T1 - Cholesteryl ester transfer protein and lecithin
T2 - Cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: Associations with total and regional body fat
AU - Greaves, Kathryn A.
AU - Going, Scott B.
AU - Fernandez, Maria Luz
AU - Milliken, Laura A.
AU - Lohman, Timothy G.
AU - Bassford, Tamsen
AU - McNamara, Donald J.
N1 - Funding Information:
Supported in part by a grant from the Arizona Disease Control Research Commission, Phoenix, AZ (9511) and by NIH Grant No. AR39939. Part of the research upon which this publication is based was performed pursuant to Contract No. N01-WH-3-201115 with the NIH, DHHS.
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Reverse cholesterol transport is one process by which high-density lipoprotein (HDL) cholesterol has been hypothesized to play a role in reducing the risk of coronary heart disease. This study was designed to examine cholesteryl ester transfer protein (CETP) and lecithin:cholesterol acyltransferase (LCAT) activities, 2 modulators of reverse cholesterol transport, in Hispanic and Anglo postmenopausal women. The associations between plasma CETP and LCAT activities and body composition were also examined. Of the 199 subjects, 33% were of Hispanic origin and 47% were undergoing hormone replacement therapy (HRT). Body composition was measured by dual-energy x-ray absorptiometry (DXA) and anthropometry. Plasma CETP activity was higher in Hispanic compared to Anglo women, although the difference was eliminated when data were adjusted for abdominal fat. Hispanic women had lower plasma HDL cholesterol concentrations, higher total cholesterol:HDL cholesterol ratios and triglyceride concentrations, and greater susceptibility of low-density lipoprotein (LDL) particles to oxidation. Hispanic women also had a significantly greater relative deposition of body fat on the trunk and intra-abdominally than did Anglo women, even after adjusting for total body fat. There were no significant ethnic differences in LCAT activity. Plasma CETP and LCAT activities were negatively correlated with HDL cholesterol and positively correlated with total cholesterol, LDL cholesterol, and triglycerides, as well as total and regional body composition variables. In conclusion, results suggest a greater risk for coronary heart disease in, Hispanic women compared to Anglo women.
AB - Reverse cholesterol transport is one process by which high-density lipoprotein (HDL) cholesterol has been hypothesized to play a role in reducing the risk of coronary heart disease. This study was designed to examine cholesteryl ester transfer protein (CETP) and lecithin:cholesterol acyltransferase (LCAT) activities, 2 modulators of reverse cholesterol transport, in Hispanic and Anglo postmenopausal women. The associations between plasma CETP and LCAT activities and body composition were also examined. Of the 199 subjects, 33% were of Hispanic origin and 47% were undergoing hormone replacement therapy (HRT). Body composition was measured by dual-energy x-ray absorptiometry (DXA) and anthropometry. Plasma CETP activity was higher in Hispanic compared to Anglo women, although the difference was eliminated when data were adjusted for abdominal fat. Hispanic women had lower plasma HDL cholesterol concentrations, higher total cholesterol:HDL cholesterol ratios and triglyceride concentrations, and greater susceptibility of low-density lipoprotein (LDL) particles to oxidation. Hispanic women also had a significantly greater relative deposition of body fat on the trunk and intra-abdominally than did Anglo women, even after adjusting for total body fat. There were no significant ethnic differences in LCAT activity. Plasma CETP and LCAT activities were negatively correlated with HDL cholesterol and positively correlated with total cholesterol, LDL cholesterol, and triglycerides, as well as total and regional body composition variables. In conclusion, results suggest a greater risk for coronary heart disease in, Hispanic women compared to Anglo women.
UR - http://www.scopus.com/inward/record.url?scp=0037355644&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037355644&partnerID=8YFLogxK
U2 - 10.1053/meta.2003.50045
DO - 10.1053/meta.2003.50045
M3 - Article
C2 - 12647264
AN - SCOPUS:0037355644
SN - 0026-0495
VL - 52
SP - 282
EP - 289
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 3
ER -